Balance Sheet
Accounts PayablesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Vanda Pharmaceuticals (VNDA) Non-Current Assets (2016 - 2025)

Historic Non-Current Assets for Vanda Pharmaceuticals (VNDA) over the last 17 years, with Q4 2025 value amounting to $141.7 million.

  • Vanda Pharmaceuticals' Non-Current Assets fell 3480.13% to $141.7 million in Q4 2025 from the same period last year, while for Dec 2025 it was $829.2 million, marking a year-over-year decrease of 307.53%. This contributed to the annual value of $141.7 million for FY2025, which is 3480.13% down from last year.
  • According to the latest figures from Q4 2025, Vanda Pharmaceuticals' Non-Current Assets is $141.7 million, which was down 3480.13% from $233.6 million recorded in Q3 2025.
  • In the past 5 years, Vanda Pharmaceuticals' Non-Current Assets registered a high of $233.6 million during Q3 2025, and its lowest value of $105.0 million during Q3 2023.
  • Over the past 5 years, Vanda Pharmaceuticals' median Non-Current Assets value was $121.5 million (recorded in 2021), while the average stood at $157.7 million.
  • As far as peak fluctuations go, Vanda Pharmaceuticals' Non-Current Assets skyrocketed by 10253.44% in 2024, and later crashed by 3480.13% in 2025.
  • Vanda Pharmaceuticals' Non-Current Assets (Quarter) stood at $115.5 million in 2021, then decreased by 0.46% to $115.0 million in 2022, then soared by 87.46% to $215.5 million in 2023, then rose by 0.84% to $217.3 million in 2024, then crashed by 34.8% to $141.7 million in 2025.
  • Its Non-Current Assets stands at $141.7 million for Q4 2025, versus $233.6 million for Q3 2025 and $229.8 million for Q2 2025.